308 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
21 Recruiting Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
Condition: Overactive Bladder
Interventions: Drug: THVD-201;   Drug: Placebo(For THVD-201);   Drug: Detrusitol 2mg tablet;   Drug: Placebo(For Detrusitol 2mg tablet)
22 Recruiting Cystoscopic Ablation Via RF Energy Clinical Trial (CARET 2)
Condition: Overactive Bladder
Intervention: Device: Amphora OAB Device 3.0 mm
23 Not yet recruiting MPDL3280A-treatment-IST-UMCG
Conditions: Bladder Cancer;   Non Small Cell Lung Cancer;   Breast Cancer
Intervention: Drug: MPDL3280A
24 Not yet recruiting Brain Areas Involved in Bladder Filling and Contraction
Condition: Urinary Bladder, Overactive
Interventions: Procedure: Uroflowmetry;   Device: fMRI
25 Not yet recruiting RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)
Condition: Bladder Cancer
Intervention: Other: Synergo® RITE + MMC
26 Not yet recruiting Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.
Condition: Overactive Bladder
Intervention: Drug: mirabegron 50mg
27 Recruiting Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement
Conditions: Urinary Bladder, Overactive;   Pain;   Lower Urinary Tract Symptoms
Interventions: Drug: Mirabegron;   Drug: Placebo
28 Not yet recruiting Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging
Condition: Muscle-invasive Bladder Cancer
Intervention: Other: Whole-body FDG PET-CT
29 Recruiting T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Conditions: Bladder Carcinoma;   Breast Cancer;   Esophagus Carcinoma;   Lung Cancer;   Melanoma;   Multiple Myeloma;   Neuroblastoma;   Ovarian Cancer;   Synovial Sarcoma;   Other Metastatic Solid Cancers
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Anti-NY ESO-1 TCR-transduced T cells
30 Not yet recruiting MPDL3280A-imaging-IST-UMCG
Conditions: Breast Cancer;   Bladder Cancer;   Non Small Cell Lung Cancer
Intervention: Other: 89Zr-MPDL-3280A-PET scans
31 Recruiting Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study
Condition: Overactive Bladder
Interventions: Device: Electroacupuncture;   Device: Sham Electroacupuncture;   Drug: Solifenacin Succinate
32 Recruiting Randomized Trial of Tibial Nerve Stimulation Versus Pelvic Floor Exercises for Treatment of Overactive Bladder
Condition: Urge Incontinence
Intervention: Other: "Tibial stimulation" and "pelvic floor exercises"
33 Recruiting IMvigor 010 Study: Anti-Programmed Death-Ligand 1 (PD-L1) Antibody MPDL3280A Treatment Versus Observation as Adjuvant Therapy in Patients With PD-L1 Positive, High Risk Muscle Invasive Bladder Cancer After Cystectomy
Condition: Bladder Cancer, Cancer
Intervention: Biological: MPDL3280A
34 Not yet recruiting Study of Tumour Focused Radiotherapy for Bladder Cancer
Condition: Bladder Cancer
Interventions: Radiation: WBRT;   Radiation: SART;   Radiation: DART
35 Not yet recruiting Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers
Conditions: LUTS;   Benign Prostatic Hyperplasia;   Overactive Bladder
Intervention: Drug: JLP-1207
36 Recruiting Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
Condition: Bladder Cancer
Interventions: Procedure: Transurethral Resection;   Drug: Tamsulosin
37 Not yet recruiting Biologic Mesh in Preventing Hernia in Patients With Bladder Cancer Undergoing Radical Cystectomy With Ileal Conduit Diversion
Conditions: Bladder Carcinoma;   Hernia
Intervention: Other: Acellular Cadaveric Dermal Matrix
38 Recruiting Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.
Conditions: Neoplasm, Ureter;   Intravesical Chemotherapy;   Radical Nephroureterectomy;   Neoplasm, Bladder
Interventions: Drug: Immediate instillation of intravesical chemotherapy-Epirubicin-;   Drug: Maintainance therapy of intravesical chemotherapy-Epirubicin-
39 Not yet recruiting Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
Conditions: Bladder Carcinoma;   Post-operative Pain
Interventions: Other: Placebo;   Other: Questionnaire Administration;   Drug: Ropivacaine Hydrochloride
40 Recruiting Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Device: Positron Emission Tomography scans

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years